Medical Sciences, Startup Technologies
Title: | Development & Commercialisation of two novel vaccines Intranasal Covid-19 Vaccine and RTS, S Malaria Vaccine |
Area: | Medical Sciences, Startup Technologies |
Focus Area: | Vaccines, Healthcare |
Status: | Commercialisation stage |
Company Transferred: | Yes |
Developing Agency: | M/s Sapigen Biologix Pvt. Ltd., Hyderabad, Telangana |
Technology Readiness Index: | TRL 9 |
Budget: | ₹311.30 Cr (TDB assistance ₹100.00 Cr) |
Funding Agency: | Technology Development Board (TDB) |
Source Title: | Technology Development Board (TDB) |
| Source (more info) : | https://tdb.gov.in/super-30-projects-2021-2030 |
Brief Description
Description : | Focused on developing India’s first intranasal Covid-19 vaccine and RTS, S Malaria vaccine, with a state-of-the-art facility in Bhubaneswar. |
Related Technologies